Incanthera's Seed VC - II Round

Incanthera raised a round of funding on February 01, 2013. Investors include North West Fund for Biomedical.

Incanthera is an oncology company with a unique pipeline of technologies that target tumors. The lead cancer therapeutic opportunity is a new chemical entity called ICT2588, which has been designed to…

Articles about Incanthera's Seed VC - II Round: